In primary CRC, such an epithelial-mesenchymal distinction is strongly prognostic, likely reflecting the metastasis promoting effect of TGFβ activation and a contribution from the tumor stroma in the mesenchymal subgroup [1]. This evidence concerns the gene TGFB1 and colorectal carcinoma.